quantisnow
FeedTopReportsPricing
⌘K
Live feed
20:40:29·77d
INSIDERFiling
ProMIS Neurosciences Inc. logo

Chief Development Officer Kaplan Johanne was granted 2,060 shares, increasing direct ownership by 817% to 2,312 units (SEC Form 4)

PMN· ProMIS Neurosciences Inc.
Health Care
Original source

Companies

  • PMN
    ProMIS Neurosciences Inc.
    Health Care

Related

  • INSIDER14h
    Director Kirwin Patrick D. bought $45,320 worth of shares (4,000 units at $11.33) (SEC Form 4)
  • SEC14d
    SEC Form DEFA14A filed by ProMIS Neurosciences Inc.
  • SEC14d
    SEC Form DEF 14A filed by ProMIS Neurosciences Inc.
  • SEC16d
    SEC Form SCHEDULE 13G filed by ProMIS Neurosciences Inc.
  • SEC21d
    SEC Form EFFECT filed by ProMIS Neurosciences Inc.
  • SEC28d
    SEC Form EFFECT filed by ProMIS Neurosciences Inc.
  • SEC29d
    SEC Form S-3 filed by ProMIS Neurosciences Inc.
  • SEC29d
    SEC Form 10-K filed by ProMIS Neurosciences Inc.
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022